158 related articles for article (PubMed ID: 26057449)
1. Association between cytosolic expression of BRCA1 and metastatic risk in breast cancer.
Santivasi WL; Wang H; Wang T; Yang Q; Mo X; Brogi E; Haffty BG; Chakravarthy AB; Xia F
Br J Cancer; 2015 Jul; 113(3):453-9. PubMed ID: 26057449
[TBL] [Abstract][Full Text] [Related]
2. Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients.
Hautala LC; Greco D; Koistinen R; Heikkinen T; Heikkilä P; Aittomäki K; Blomqvist C; Koistinen H; Nevanlinna H
Breast Cancer Res Treat; 2011 Jul; 128(1):85-95. PubMed ID: 20676758
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of metastatic behaviour of breast cancer subtypes.
Savci-Heijink CD; Halfwerk H; Hooijer GK; Horlings HM; Wesseling J; van de Vijver MJ
Breast Cancer Res Treat; 2015 Apr; 150(3):547-57. PubMed ID: 25820592
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of BRCA1 expression in sporadic breast carcinomas.
Lambie H; Miremadi A; Pinder SE; Bell JA; Wencyk P; Paish EC; Macmillan RD; Ellis IO
J Pathol; 2003 Jun; 200(2):207-13. PubMed ID: 12754741
[TBL] [Abstract][Full Text] [Related]
5. Expression of BRCA1 protein in breast cancer and its prognostic significance.
Rakha EA; El-Sheikh SE; Kandil MA; El-Sayed ME; Green AR; Ellis IO
Hum Pathol; 2008 Jun; 39(6):857-65. PubMed ID: 18400253
[TBL] [Abstract][Full Text] [Related]
6. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
7. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer.
Neumeister VM; Sullivan CA; Lindner R; Lezon-Geyda K; Li J; Zavada J; Martel M; Glazer PM; Tuck DP; Rimm DL; Harris L
Breast Cancer Res Treat; 2012 Nov; 136(1):67-75. PubMed ID: 22976806
[TBL] [Abstract][Full Text] [Related]
9. Effect of BRCA1 immunohistochemical localizations on prognosis of patients with sporadic breast carcinomas.
Mylona E; Melissaris S; Nomikos A; Theohari I; Giannopoulou I; Tzelepis K; Nakopoulou L
Pathol Res Pract; 2014 Aug; 210(8):533-40. PubMed ID: 24947414
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
[TBL] [Abstract][Full Text] [Related]
11. A mutation in the 5' untranslated region of the BRCA1 gene in sporadic breast cancer causes downregulation of translation efficiency.
Wang J; Lu C; Min D; Wang Z; Ma X
J Int Med Res; 2007; 35(4):564-73. PubMed ID: 17697535
[TBL] [Abstract][Full Text] [Related]
12. Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer.
Hedau S; Batra M; Singh UR; Bharti AC; Ray A; Das BC
J Cancer Res Ther; 2015; 11(1):158-63. PubMed ID: 25879355
[TBL] [Abstract][Full Text] [Related]
13. Biological and clinical significance of PARP1 protein expression in breast cancer.
Green AR; Caracappa D; Benhasouna AA; Alshareeda A; Nolan CC; Macmillan RD; Madhusudan S; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2015 Jan; 149(2):353-62. PubMed ID: 25528020
[TBL] [Abstract][Full Text] [Related]
14. Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective.
Naushad SM; Reddy CA; Kumaraswami K; Divyya S; Kotamraju S; Gottumukkala SR; Digumarti RR; Kutala VK
Cell Biochem Biophys; 2014 Mar; 68(2):397-406. PubMed ID: 23934182
[TBL] [Abstract][Full Text] [Related]
15. Microcephalin is a new novel prognostic indicator in breast cancer associated with BRCA1 inactivation.
Richardson J; Shaaban AM; Kamal M; Alisary R; Walker C; Ellis IO; Speirs V; Green AR; Bell SM
Breast Cancer Res Treat; 2011 Jun; 127(3):639-48. PubMed ID: 20632086
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 in non-inherited breast carcinomas (Review).
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Oncol Rep; 2002; 9(6):1329-33. PubMed ID: 12375043
[TBL] [Abstract][Full Text] [Related]
17. Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy.
Patel AN; Goyal S; Wu H; Schiff D; Moran MS; Haffty BG
Breast Cancer Res Treat; 2011 Apr; 126(3):601-7. PubMed ID: 20521098
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 mislocalization associated with breast carcinogenesis and poor prognosis in Taiwanese women.
Ho JY; Hsu RJ; Wu CL; Chen SH; Wu MY; Yu JC; Gao HW; Yen AM; Chen HH; Yu CP
Eur J Cancer Prev; 2015 Sep; 24(5):407-15. PubMed ID: 25622084
[TBL] [Abstract][Full Text] [Related]
19. Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.
Heublein S; Mayr D; Meindl A; Angele M; Gallwas J; Jeschke U; Ditsch N
PLoS One; 2015; 10(6):e0127072. PubMed ID: 26029931
[TBL] [Abstract][Full Text] [Related]
20. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM
Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
